09:52 AM EST - Concordia Healthcare Corp. : announced today that it has entered into a definitive agreement to acquire Donnatal®, an adjunctive therapy in the treatment of irritable bowel syndrome and acute enterocolitis, from a privately held specialty pharmaceutical company carrying on business as Revive Pharmaceuticals. Concordia Healthcare Corp.
shares T.CXR are trading up $0.42 at $16.25.
